Skip to content
More than 10 million French people have been vaccinated with at least one dose

Published on :

France has just passed the milestone of 10 million people who have received at least a first injection of the Covid-19 vaccine, greeted Prime Minister Jean Castex on Thursday. Next goal: to have injected 30 million doses in mid-June.

“Commitment kept”, welcomed Jean Castex. France crossed, Thursday, April 8, the threshold of 10 million people who received a first injection of the vaccine against Covid-19, announced the Prime Minister.

The country “has just passed the 10 million people who received a first vaccination, that is to say that we are a week ahead of (on) the target I had set. It is a very good performance, France vaccinates a lot “, welcomed the head of government.

“And this is due to (…) all those who are seven days a week on the bridge in the service of this great national cause which is called vaccination and which will allow us to get out of this crisis,” he said. he declared after his visit to a vaccination center in Nogent-sur-Marne, in Val-de-Marne, east of Paris.

30 million first injected doses are expected in mid-June

The government had set a target of vaccinating 10 million people with at least a first dose by mid-April. At a daily rate of 200,000 to 300,000 vaccinations, this goal was reached a few days early.

It also plans to vaccinate 20 million people in mid-May, then 30 million in mid-June.

“We now have the target of 20 million, and I have no doubt that thanks to this general mobilization we will achieve it,” assured Jean Castex on Thursday.

In the vaccination center, the Prime Minister spoke to a doctor about the AstraZeneca vaccines, which arouse reluctance due to some very rare side effects. “You are in the best position to overcome reluctance, to explain to your own patients and to convince them” about the AstraZeneca vaccine, Jean Castex told him.

“This is what we do,” replied the doctor, who considered “tiny” the number of cases of thrombosis after an injection of AstraZeneca, compared to the general population.

With AFP


Source link